The largest database of trusted experimental protocols

Nih 3 t3 cells

Manufactured by Lonza

NIH/3T3 cells are a commonly used mouse embryonic fibroblast cell line. They are a standardized, well-characterized cell line that can be used for various cell culture applications.

Automatically generated - may contain errors

2 protocols using nih 3 t3 cells

1

Bmpr1b Variant Transcriptional Regulation

Check if the same lab product or an alternative is used in the 5 most similar protocols
NIH/3 T3 cells (ATCC) were seeded in a 96-well plate in growth medium (DMEM 4.5 g/l glucose (Lonza), 10 % FBS superior (Biochrom), 2 mM L-glutamine (Lonza)) and transfected 24 h later using Lipofectamine 2000 (Invitrogen, Life Technologies) following the manufacturer´s instructions. Cells were transfected in growth medium with the control vector pCS2+ or one of the Bmpr1b variants in pCS2+ together with the BRE luciferase reporter construct BRE-pLG3ti [14 (link)] and the Renilla luciferase normalization vector pRL-TK (Promega). After 18 h cells were stimulated with 2 nM human recombinant GDF5 (Biopharm) in serum-reduced medium (DMEM 4.5 g/l glucose (Lonza), 1 % FBS superior (Biochrom), 2 mM L-glutamine (Lonza)). 40 h after transfection cells were lysed in potassium phosphate buffer (9 mM potassium di-hydrogen phosphate, 91 mM di-potassium phosphate, 0.2 % Triton-X-100) and dual luciferase activity was measured as described previously [15 (link)] using the Mithras LB 940 (Berthold Technologies). For statistical analysis GraphPad Prism 5 (GraphPad Software, Inc.) was used.
+ Open protocol
+ Expand
2

Evaluating miRNA-26a Cytotoxicity Against Leukemia Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
CLL cells (American Type Culture Collection; ATCC; Manassas, VA, USA) were maintained in RPMI medium supplemented with 10% FBS (Lonza Group, Ltd., Basel, Switzerland) and 1% penicillin-streptomycin antibiotic mixture in an atmosphere of 65% humidity with 5% CO2 and 37°C. The cells were seeded in 96-well plates at a density of 1.2×104 cells per well and incubated for 24 h. The cells were then treated with miRNA-loaded liposomes or blank liposomes (0.1, 1, 10, 50 and 100 µM) and incubated for a further 24 h. The cells were treated for 24 h with increasing concentrations of miRNA-26a (25, 50 and 100 µM) to study concentration-dependent cytotoxicity against leukemia cells. Untreated cells were maintained throughout the study period. The cells were treated with 100 µl 1.25 mg/ml MTT solution and incubated for 4 h at 37°C, after which the formazan crystals were dissolved in DMSO. The absorbance was determined at 570 nm using a microplate reader (Infinite M200 reader; Tecan, Männedorf, Switzerland). For comparison, NIH-3T3 cells (ATCC) was purchased and grown in RPMI medium supplemented with 10% FBS (Lonza Group, Ltd.) and 1% penicillin-streptomycin antibiotic mixture in a humidified atmosphere (65%) with 5% CO2 and 37°C. The same protocol was followed for MTT assay of these cells.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!